Affinity Asset Advisors’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-100,000
Closed -$9.7M – 125
2026
Q1
$9.7M Buy
+100,000
New +$10.1M 0.5% 52

Other funds holding RVMD

Affinity Asset Advisors's RVMD Position: Q3 2026 in Review

Affinity Asset Advisors reduced its Revolution Medicines (RVMD) stake by 10% in Q3 2026, selling an estimated $4.96M and leaving 225,000 shares worth $46.2M. The position accounts for 1.88% of the portfolio, ranked #17.

Affinity Asset Advisors first reported a position in RVMD in Q3 2025 and has held it in 5 quarters since. The position peaked at $46.8M in Q2 2026. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Affinity Asset Advisors held 225,000 shares of Revolution Medicines worth $46.2M as of Q3 2026.
  • Affinity Asset Advisors sold 25,000 Revolution Medicines shares in Q3 2026, an estimated $4.96M.
  • Revolution Medicines made up 1.88% of Affinity Asset Advisors's portfolio in Q3 2026, its #17 holding.
  • Affinity Asset Advisors first reported a position in Revolution Medicines in Q3 2025 and has held it in 5 quarters since.
  • Affinity Asset Advisors's Revolution Medicines position peaked at $46.8M in Q2 2026.
  • 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Affinity Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.